Written Question·Department of Health and Social Care·UIN 99268

Vorasidenib

Tabled: 11 December 2025

Answered: 18 December 2025

Question

Charlotte Nichols

To ask the Secretary of State for Health and Social Care, when he expects the drug Vorsidenib (Voranigo) to be made available to treat adults and children aged 12 years and over with grade 2 astrocytoma or oligodendroglioma carrying a susceptible IDH1 or

Answer

Dr Zubir Ahmed

The National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations on whether new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost e...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 99268) →